These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26609306)

  • 1. Current State of Vascular Resections in Pancreatic Cancer Surgery.
    Hackert T; Schneider L; Büchler MW
    Gastroenterol Res Pract; 2015; 2015():120207. PubMed ID: 26609306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline resectable pancreatic cancer.
    Hackert T; Ulrich A; Büchler MW
    Cancer Lett; 2016 Jun; 375(2):231-237. PubMed ID: 26970276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019.
    Delpero JR; Sauvanet A
    Front Oncol; 2020; 10():40. PubMed ID: 32117714
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgery for Pancreatic Cancer after neoadjuvant treatment.
    Hackert T
    Ann Gastroenterol Surg; 2018 Nov; 2(6):413-418. PubMed ID: 30460344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion Surgery for Pancreatic Cancer-The Impact of Neoadjuvant Treatment.
    Klaiber U; Hackert T
    Front Oncol; 2019; 9():1501. PubMed ID: 31993372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical Implications for Surgical Resection in Locally Advanced Pancreatic Cancer.
    de Santibañes M; Pekolj J; Sanchez Claria R; de Santibañes E; Mazza OM
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.
    Heinrich S; Besselink M; Moehler M; van Laethem JL; Ducreux M; Grimminger P; Mittler J; Lang H; Lutz MP; Lesurtel M;
    BMC Cancer; 2019 Jul; 19(1):675. PubMed ID: 31288786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New challenges in perioperative management of pancreatic cancer.
    Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
    World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary strategies to improve the outcome in locally advanced pancreatic cancer.
    Schneider R; Späth C; Nitsche U; Erkan M; Kleeff J
    Minerva Chir; 2017 Oct; 72(5):424-431. PubMed ID: 28565894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pancreatic cancer: challenge of the facts.
    Beger HG; Rau B; Gansauge F; Poch B; Link KH
    World J Surg; 2003 Oct; 27(10):1075-84. PubMed ID: 12925907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical pancreatic cancer surgery-with arterial resection.
    Klaiber U; Mihaljevic A; Hackert T
    Transl Gastroenterol Hepatol; 2019; 4():8. PubMed ID: 30976711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current state of surgical management of pancreatic cancer.
    Hackert T; Büchler MW; Werner J
    Cancers (Basel); 2011 Mar; 3(1):1253-73. PubMed ID: 24212660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radical procedures in patients with pancreatic cancer--impact on prolongation and quality of life].
    Ryska M
    Rozhl Chir; 2010 Dec; 89(12):725-30. PubMed ID: 21404511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer.
    Strobel O; Berens V; Hinz U; Hartwig W; Hackert T; Bergmann F; Debus J; Jäger D; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S33-42. PubMed ID: 22770956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pancreatic cancer-neoadjuvant treatment in resectable pancreatic cancer (PDAC).
    Seufferlein T; Ettrich TJ
    Transl Gastroenterol Hepatol; 2019; 4():21. PubMed ID: 30976724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical options in the management of pancreatic cancer.
    Hackert T; Büchler MW; Werner J
    Minerva Chir; 2009 Oct; 64(5):465-76. PubMed ID: 19859037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer.
    Scheufele F; Hartmann D; Friess H
    Transl Gastroenterol Hepatol; 2019; 4():32. PubMed ID: 31231699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).
    Schwarz L; Vernerey D; Bachet JB; Tuech JJ; Portales F; Michel P; Cunha AS
    BMC Cancer; 2018 Jul; 18(1):762. PubMed ID: 30041614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local radicality and survival outcome of pancreatic cancer surgery.
    Niesen W; Hank T; Büchler M; Strobel O
    Ann Gastroenterol Surg; 2019 Sep; 3(5):464-475. PubMed ID: 31549006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.